These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 3889253)

  • 41. An evaluation of antipseudomonal antimicrobic agents.
    Gilbert DN
    Antibiot Chemother (1971); 1985; 36():111-33. PubMed ID: 3923909
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A randomized trial of empirical antibiotic therapy with one of four beta-lactam antibiotics in combination with netilmicin in febrile neutropenic patients.
    Sage R; Hann I; Prentice HG; Devereux S; Corringham R; Hoffbrand AV; Blacklock H; Stirling L; Guimaraes M; Trikka E
    J Antimicrob Chemother; 1988 Aug; 22(2):237-47. PubMed ID: 3053555
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of aminoglycosides in immunocompromised patients.
    Young LS
    Am J Med; 1985 Jul; 79(1A):21-7. PubMed ID: 4025366
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Controversies in the management of febrile neutropenic cancer patients.
    Rubin M; Hathorn JW; Pizzo PA
    Cancer Invest; 1988; 6(2):167-84. PubMed ID: 3132310
    [No Abstract]   [Full Text] [Related]  

  • 45. Clinical guidelines for the management of neutropenic patients with unexplained fever in Japan: validation by the Japan Febrile Neutropenia Study Group.
    Tamura K
    Int J Antimicrob Agents; 2005 Dec; 26 Suppl 2():S123-7; discussion S133-40. PubMed ID: 16249072
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Empirical antibiotics for febrile neutropenic cancer patients.
    Hathorn JW
    Eur J Cancer Clin Oncol; 1989; 25 Suppl 2():S43-51. PubMed ID: 2693109
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Empirical antibiotic therapy for fever in neutropenic patients.
    Bodey GP
    Clin Infect Dis; 1993 Nov; 17 Suppl 2():S378-84. PubMed ID: 8274604
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Use of empiric antimicrobial therapy in neutropenic fever. Australian Consensus Guidelines 2011 Steering Committee.
    Tam CS; O'Reilly M; Andresen D; Lingaratnam S; Kelly A; Burbury K; Turnidge J; Slavin MA; Worth LJ; Dawson L; Thursky KA;
    Intern Med J; 2011 Jan; 41(1b):90-101. PubMed ID: 21272173
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Monotherapy for empirical management of febrile neutropenic patients.
    Rubin M; Pizzo PA
    NCI Monogr; 1990; (9):111-6. PubMed ID: 2160613
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Aztreonam in the prevention and treatment of infection in neutropenic cancer patients.
    Rolston KV; Bodey GP; Elting L
    Am J Med; 1990 Mar; 88(3C):24S-29S; discussion 38S-42S. PubMed ID: 2180294
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prophylaxis and treatment of bacterial infections: do we need new strategies?
    Micozzi A; Bucaneve G
    Rev Clin Exp Hematol; 2005 Dec; 9(2):E4. PubMed ID: 16864118
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Monotherapy for empiric treatment of fever in granulocytopenic cancer patients.
    Wade JC; Johnson DE; Bustamante CI
    Am J Med; 1986 May; 80(5C):85-95. PubMed ID: 3521273
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Imipenem/cilastatin versus piperacillin/tazobactam plus amikacin for empirical therapy in febrile neutropenic patients: results of the COSTINE study.
    Sanz MA; Bermúdez A; Rovira M; Besalduch J; Pascual MJ; Nocea G; Sanz-Rodríguez C;
    Curr Med Res Opin; 2005 May; 21(5):645-55. PubMed ID: 15969864
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Additional anti-Gram-positive antibiotic treatment for febrile neutropenic cancer patients.
    Paul M; Borok S; Fraser A; Vidal L; Cohen M; Leibovici L
    Cochrane Database Syst Rev; 2005 Jul; (3):CD003914. PubMed ID: 16034915
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Single-agent therapy for infections in neutropenic cancer patients.
    Fainstein V; Bodey GP
    Am J Med; 1985 Aug; 79(2A):83-8. PubMed ID: 3895923
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Is the addition of aminoglycosides to beta-lactams in cancer patients with febrile neutropenia needed?
    Contreras V; Sepúlveda S; Heredia A
    Medwave; 2016 Feb; 16 Suppl 1():e6379. PubMed ID: 26938974
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An evaluation of empirical antibiotic therapy in febrile neutropenic patients.
    Barnes RA; Rogers TR
    Br J Haematol; 1987 May; 66(1):137-40. PubMed ID: 3593650
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Initial empirical antibiotic therapy for neutropenic fever: analysis of the causes of death.
    Rossi C; Klastersky J
    Support Care Cancer; 1996 May; 4(3):207-12. PubMed ID: 8739654
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Randomized comparison of cefepime versus ceftazidime monotherapy for fever and neutropenia in children with solid tumors.
    Kebudi R; Görgün O; Ayan I; Gürler N; Akici F; Töreci K
    Med Pediatr Oncol; 2001 Apr; 36(4):434-41. PubMed ID: 11260566
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cefepime monotherapy for treatment of febrile neutropenia in children.
    Ariffin H; Ai CL; Lee CL; Abdullah WA
    J Paediatr Child Health; 2006 Dec; 42(12):781-4. PubMed ID: 17096713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.